European BE study for Canada? [Regulatives / Guidelines]

posted by jag009  – NJ, 2012-05-30 20:13 (5139 d 19:06 ago) – Posting: # 8633
Views: 2,502

Hi Dr. Dan,

1) I don't think TPD (Canada) will enforce the blinded issue. We submitted US FDA open-label studies (BE and NDA) for Canadian filing and they were okay.
2) Are the names of the innovator product (Euro and Canada) the same?

John


Edit: Full quote removed. Please delete anything from the text of the original poster which is not necessary in understanding your answer; see also this post! [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
368 visitors (0 registered, 368 guests [including 22 identified bots]).
Forum time: 15:20 CEST (Europe/Vienna)

Ignorance more frequently begets confidence
than does knowledge.    Charles Darwin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5